Toronto Dominion Bank Purchases 1,111 Shares of Solventum Co. (NYSE:SOLV)

Toronto Dominion Bank raised its position in shares of Solventum Co. (NYSE:SOLV) by 1.6% during the third quarter, HoldingsChannel.com reports. The fund owned 71,096 shares of the company’s stock after buying an additional 1,111 shares during the quarter. Toronto Dominion Bank’s holdings in Solventum were worth $4,957,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Copeland Capital Management LLC bought a new stake in shares of Solventum during the 3rd quarter valued at about $26,000. Mather Group LLC. acquired a new position in Solventum in the third quarter valued at approximately $27,000. Hollencrest Capital Management acquired a new position in Solventum in the second quarter valued at approximately $25,000. True Wealth Design LLC boosted its holdings in shares of Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after buying an additional 471 shares in the last quarter. Finally, Deseret Mutual Benefit Administrators acquired a new stake in shares of Solventum during the 2nd quarter worth approximately $25,000.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on SOLV. Wolfe Research initiated coverage on shares of Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating on the stock. Mizuho began coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective on the stock. Stifel Nicolaus started coverage on Solventum in a research report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price for the company. BTIG Research started coverage on Solventum in a research note on Thursday, September 5th. They set a “neutral” rating on the stock. Finally, Morgan Stanley raised their price objective on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Trading Down 0.6 %

Shares of NYSE SOLV opened at $69.56 on Friday. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The firm’s 50-day simple moving average is $70.91 and its 200 day simple moving average is $63.22. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.